One of Deepbridge Capital's Life Sciences Investment Managers, Ben Carter, recently spoke to IFA Magazine about the role of an investment manager and goes into more detail of the dealflow, networks and sector specific expertise of the Deepbridge Life Sciences EIS portfolio.
Ocutec, which is part of the Deepbridge Technology Growth EIS portfolio, has recently secured £1.5 million in a seed funding round that was led by Deepbridge Capital.
Summary of the Deepbridge Explore Webinar
Simon Tutton, Regional Director (South West England and South Wales), Deepbridge Capital
As of 16th February 2022, Deepbridge Capital is opening a new £1 million tranche of the Deepbridge Innovation SEIS fund.
Andrew Aldridge, Partner and Head of Marketing at Deepbridge, recently spoke with Professional Adviser to share his thoughts regarding the world of tax-efficient investments and assesses which relief is the trump card for advisers and clients.
IbisVision, which is part of the Deepbridge Life Sciences EIS portfolio, has recently been featured on The Seven on BBC Scotland. This interview was filmed in the Glasgow Science Centre.
Deepbridge Capital has been shortlisted for the Deal of the Year (Transaction size below £2.5 million) Award at the upcoming 2022 Insider Media, Northern Ireland Dealmakers Awards.
Hy-genie, a portfolio company within the Deepbridge Life Sciences EIS fund, was a worthy winner of Business Cloud's MedTech 50 innovation ranking last year - with the help from Alder Hey Children's Hospital in its progress.
GBI Magazine recently spoke to Sameer Kothari, Chief Executive Director of Zilico Ltd, to talk about his Start-Up journey and how the Deepbridge Life Sciences EIS Scheme influenced it.
Recently, GBI Magazine sat down with FluoretiQ Co-Founder & CEO, Neciah Dorh, to talk about his Start-Up journey and how the Deepbridge Life Sciences EIS Scheme influenced it.
